Product Information
VALTOCO 20 MG NASAL SPRAY is a brand product labeled by Neurelis, Inc, priced at $365.6363 per EA under NDC 72252052010. Its NADAC has been published 63 times since Jul 23, 2025.
FDA first approved this application on Jan 10, 2020.
Strength
10 mg/.1mL
Manufacturer
Neurelis, IncNDC
72252052010
Classification
Brand
Dosage Form
SPRAY
Route
NASAL
Effective Date
9/23/2026
Active Ingredients
DIAZEPAMApproval Type
New Drug (NDA)
FDA Application
NDA211635FDA Approved
1/10/2020
On Market Since
1/10/2020
Pharmacological Classes
Price Statistics
The NADAC for VALTOCO 20 MG NASAL SPRAY has been published 63 times since Jul 23, 2025, and over the history we have for it it has risen 4.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $365.6363 per EA |
|---|---|
| All-time high | $366.0278 (Jun 10, 2026) |
| All-time low | $348.8434 (Jul 23, 2025) |
| 52-week high | $366.0278 |
| 52-week low | $349.3138 |
| Median price | $365.3989 |
| Average price | $359.4287 |
| Largest weekly change | +4.5% (Jan 7, 2026) |
| Weeks tracked | 63 |
| Tracking since | Jul 23, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Neurelis, Inc manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
diazepam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VALTOCO 20 MG NASAL SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for VALTOCO 20 MG NASAL SPRAY, manufactured by Neurelis, Inc, is $365.6363 per EA (NDC 72252052010), effective Sep 30, 2026.
How has the price of VALTOCO 20 MG NASAL SPRAY changed over time?
Over the history we have for it, the NADAC for VALTOCO 20 MG NASAL SPRAY has risen 4.8%. It has been tracked across 63 weekly CMS publications since Jul 23, 2025.
What are the highest and lowest recorded NADAC prices for VALTOCO 20 MG NASAL SPRAY?
Since Jul 23, 2025, the NADAC for VALTOCO 20 MG NASAL SPRAY has ranged from a low of $348.8434 (Jul 23, 2025) to a high of $366.0278 (Jun 10, 2026), with a median of $365.3989 per EA.
Are there cheaper alternatives to VALTOCO 20 MG NASAL SPRAY?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VALTOCO 10 MG NASAL SPRAY, is $365.4679 per EA — about 0% below VALTOCO 20 MG NASAL SPRAY.
Who manufactures VALTOCO 20 MG NASAL SPRAY?
VALTOCO 20 MG NASAL SPRAY (NDC 72252052010) is labeled by Neurelis, Inc, and CMS classifies it as a brand product.